Ana Laura De Sene Amâncio Zara
Biographic Data
| ID | 1794177 |
|---|---|
| NAME | Ana Laura De Sene Amâncio Zara |
| GIVEN NAMES | Ana Laura De Sene Amâncio |
| FAMILY NAME | Zara |
| SIGNATURE | ZARA A L S A |
| AFFILIATIONS | Universidade Federal de Goiás |
| ORCID | 0000-0001-7012-9078 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Vigilância em saúde no enfrentamento da Covid-19 no Brasil
O manejo da pandemia de COVID-19 no Brasil foi marcado por discursos contraditórios e decisões controversas por parte do chefe do poder executivo e do Ministério da Saúde, o que gerou incertezas quanto à implantação e implementação de ações federais eficazes no controle da doença. O presente estudo tem como objetivo descrever as principais estratégias de vigilância em saúde adotadas pelo governo federal para o enfrentamento da COVID-19, com foco …
Health surveillance in tackling Covid-19 in Brazil
The management of the COVID-19 pandemic in Brazil was marked by contradictory statements and controversial decisions by the head of the executive branch and the Ministry of Health, creating uncertainty about the effective implementation of federal actions to control the disease. This study aims to describe the main health surveillance strategies adopted by the federal government to combat COVID-19, with a focus on actions aimed at preventing SARS…
Potential kidney damage associated with the use of remdesivir for Covid-19
The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events. The available information on the renal safety profile for remdesivir is limited, thus we analyzed the renal and urinary adverse reactions attributed to remdesivir reported in a large open pharmacovigilance database. W…
No prominent works on this page.
Vigilância em saúde no enfrentamento da Covid-19 no Brasil
O manejo da pandemia de COVID-19 no Brasil foi marcado por discursos contraditórios e decisões controversas por parte do chefe do poder executivo e do Ministério da Saúde, o que gerou incertezas quanto à implantação e implementação de ações federais eficazes no controle da doença. O presente estudo tem como objetivo descrever as principais estratégias de vigilância em saúde adotadas pelo governo federal para o enfrentamento da COVID-19, com foco …
Health surveillance in tackling Covid-19 in Brazil
The management of the COVID-19 pandemic in Brazil was marked by contradictory statements and controversial decisions by the head of the executive branch and the Ministry of Health, creating uncertainty about the effective implementation of federal actions to control the disease. This study aims to describe the main health surveillance strategies adopted by the federal government to combat COVID-19, with a focus on actions aimed at preventing SARS…
Potential kidney damage associated with the use of remdesivir for Covid-19
The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events. The available information on the renal safety profile for remdesivir is limited, thus we analyzed the renal and urinary adverse reactions attributed to remdesivir reported in a large open pharmacovigilance database. W…
Medicine (3 works) · 2019-20 coronavirus outbreak (1 work) · Acute kidney injury (1 work) · Adverse effect (1 work) · Adverse Event Reporting System (1 work) · Art (1 work) · Computer Science (1 work) · Coronavirus disease 2019 (COVID-19) (1 work) · COVID-19 and healthcare impacts (1 work) · COVID-19 Clinical Research Studies (1 work)